Affinia Therapeutics
Biotechnology company focused on creating transformative gene therapies for devastating genetic diseases.
Notes
Biotechnology company focused on creating transformative gene therapies for devastating genetic diseases.
Additional Research Findings
- Raised $60 million in Series A funding round (March 2020)
- Investor: Alexandria Venture Investments
- Focus on gene therapy for genetic diseases
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Alexandria Venture Investments | Pasadena, USA | cvc | seedseries-a+3 | 6 |